{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:15:39Z","timestamp":1780359339598,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Drug-drug interaction (DDI) is a serious public health issue. The L1000 database of the LINCS project has collected millions of genome-wide expressions induced by 20,000 small molecular compounds on 72 cell lines. Whether this unified and comprehensive transcriptome data resource can be used to build a better DDI prediction model is still unclear. Therefore, we developed and validated a novel deep learning model for predicting DDI using 89,970 known DDIs extracted from the DrugBank database (version 5.1.4).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The proposed model consists of a graph convolutional autoencoder network (GCAN) for embedding drug-induced transcriptome data from the L1000 database of the LINCS project; and a long short-term memory (LSTM) for DDI prediction. Comparative evaluation of various machine learning methods demonstrated the superior performance of our proposed model for DDI prediction. Many of our predicted DDIs were revealed in the latest DrugBank database (version 5.1.7). In the case study, we predicted drugs interacting with<jats:italic>sulfonylureas<\/jats:italic>to cause hypoglycemia and drugs interacting with<jats:italic>metformin<\/jats:italic>to cause lactic acidosis, and showed both to induce effects on the proteins involved in the metabolic mechanism in vivo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The proposed deep learning model can accelerate the discovery of new DDIs. It can support future clinical research for safer and more effective drug co-prescription.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12859-021-04241-1","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T10:03:18Z","timestamp":1623405798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Novel deep learning-based transcriptome data analysis for drug-drug interaction prediction with an application in diabetes"],"prefix":"10.1186","volume":"22","author":[{"given":"Qichao","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"4241_CR1","first-page":"e2800","volume":"24","author":"MCS Rodrigues","year":"2015","unstructured":"Rodrigues MCS, de Oliveira C. Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review. Rev Lat Am Enfermagem. 2015;24:e2800.","journal-title":"Rev Lat Am Enfermagem"},{"key":"4241_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","volume":"176","author":"DM Qato","year":"2016","unstructured":"Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176:473\u201382.","journal-title":"JAMA Intern Med"},{"key":"4241_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.amjopharm.2011.10.004","volume":"9","author":"LE Hines","year":"2011","unstructured":"Hines LE, Murphy JE. Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother. 2011;9:364\u201377.","journal-title":"Am J Geriatr Pharmacother"},{"key":"4241_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.sapharm.2017.07.004","volume":"14","author":"J Jazbar","year":"2018","unstructured":"Jazbar J, Locatelli I, Horvat N, Kos M. Clinically relevant potential drug-drug interactions among outpatients: a nationwide database study. Res Soc Adm Pharm. 2018;14:572\u201380.","journal-title":"Res Soc Adm Pharm"},{"key":"4241_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12916-015-0322-7","volume":"13","author":"B Guthrie","year":"2015","unstructured":"Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995\u20132010. BMC Med. 2015;13:74.","journal-title":"BMC Med"},{"key":"4241_CR6","first-page":"282","volume":"8","author":"S Mousavi","year":"2017","unstructured":"Mousavi S, Ghanbari G. Potential drug-drug interactions among hospitalized patients in a developing country. Caspian J Intern Med. 2017;8:282\u20138.","journal-title":"Caspian J Intern Med"},{"key":"4241_CR7","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.clgc.2019.05.016","volume":"18","author":"D Hebenstreit","year":"2020","unstructured":"Hebenstreit D, Pichler R, Heidegger I. Drug-drug interactions in prostate cancer treatment. Clin Genitourin Cancer. 2020;18:e71-82.","journal-title":"Clin Genitourin Cancer"},{"key":"4241_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2013.01.006","volume":"34","author":"B Percha","year":"2013","unstructured":"Percha B, Altman RB. Informatics confronts drug-drug interactions. Trends Pharmacol Sci. 2013;34:178\u201384.","journal-title":"Trends Pharmacol Sci"},{"key":"4241_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/amiajnl-2011-000214","volume":"19","author":"NP Tatonetti","year":"2012","unstructured":"Tatonetti NP, Fernald GH, Altman RB. A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports. J Am Med Inform Assoc. 2012;19:79\u201385.","journal-title":"J Am Med Inform Assoc"},{"key":"4241_CR10","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1016\/j.bbagen.2013.05.005","volume":"1830","author":"K Yamasaki","year":"2013","unstructured":"Yamasaki K, Chuang VTG, Maruyama T, Otagiri M. Albumin-drug interaction and its clinical implication. Biochim Biophys Acta. 2013;1830:5435\u201343.","journal-title":"Biochim Biophys Acta"},{"key":"4241_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12916-016-0553-2","volume":"14","author":"IJ Onakpoya","year":"2016","unstructured":"Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 2016;14:10.","journal-title":"BMC Med"},{"key":"4241_CR12","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, et al. A landscape of pharmacogenomic interactions in cancer. Cell. 2016;166:740\u201354.","journal-title":"Cell"},{"key":"4241_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","volume":"521","author":"Y LeCun","year":"2015","unstructured":"LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436\u201344.","journal-title":"Nature"},{"key":"4241_CR14","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1021\/acs.molpharmaceut.5b00982","volume":"13","author":"P Mamoshina","year":"2016","unstructured":"Mamoshina P, Vieira A, Putin E, Zhavoronkov A. Applications of deep learning in biomedicine. Mol Pharm. 2016;13:1445\u201354.","journal-title":"Mol Pharm"},{"key":"4241_CR15","doi-asserted-by":"publisher","first-page":"E4304","DOI":"10.1073\/pnas.1803294115","volume":"115","author":"JY Ryu","year":"2018","unstructured":"Ryu JY, Kim HU, Lee SY. Deep learning improves prediction of drug-drug and drug-food interactions. Proc Natl Acad Sci USA. 2018;115:E4304\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4241_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12859-019-3013-0","volume":"20","author":"G Lee","year":"2019","unstructured":"Lee G, Park C, Ahn J. Novel deep learning model for more accurate prediction of drug-drug interaction effects. BMC Bioinform. 2019;20:415.","journal-title":"BMC Bioinform"},{"key":"4241_CR17","doi-asserted-by":"publisher","first-page":"13645","DOI":"10.1038\/s41598-019-50121-3","volume":"9","author":"N Rohani","year":"2019","unstructured":"Rohani N, Eslahchi C. Drug-drug interaction predicting by neural network using integrated similarity. Sci Rep. 2019;9:13645.","journal-title":"Sci Rep"},{"key":"4241_CR18","doi-asserted-by":"crossref","unstructured":"Karim MdR, Cochez M, Jares JB, Uddin M, Beyan O, Decker S. Drug-drug interaction prediction based on knowledge graph embeddings and convolutional-LSTM network. In: Proceedings of the 10th ACM international conference on bioinformatics, computational biology and health informatics. 2019: 113\u2013123.","DOI":"10.1145\/3307339.3342161"},{"key":"4241_CR19","doi-asserted-by":"crossref","unstructured":"Zheng X, He S, Song X, Zhang Z, Bo X. DTI-RCNN: new efficient hybrid neural network model to predict drug\u2013target interactions. In: International conference on artificial neural networks. Springer, Cham, 2018: 104\u2013114.","DOI":"10.1007\/978-3-030-01418-6_11"},{"key":"4241_CR20","unstructured":"Dhami DS, Yan S, Kunapuli G, Page D, Natarajan S. Beyond textual data: predicting drug-drug interactions from molecular structure images using siamese neural networks. 2019. arXiv preprint http:\/\/arxiv.org\/abs\/1911.06356."},{"key":"4241_CR21","unstructured":"Kipf TN, Welling M. Semi-supervised classification with graph convolutional networks. 2016. arXiv preprint http:\/\/arxiv.org\/abs\/1609.02907."},{"key":"4241_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12859-020-03724-x","volume":"21","author":"Y-H Feng","year":"2020","unstructured":"Feng Y-H, Zhang S-W, Shi J-Y. DPDDI: a deep predictor for drug-drug interactions. BMC Bioinform. 2020;21:419.","journal-title":"BMC Bioinform"},{"key":"4241_CR23","doi-asserted-by":"publisher","first-page":"i457","DOI":"10.1093\/bioinformatics\/bty294","volume":"34","author":"M Zitnik","year":"2018","unstructured":"Zitnik M, Agrawal M, Leskovec J. Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics. 2018;34:i457\u201366.","journal-title":"Bioinformatics"},{"key":"4241_CR24","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/amiajnl-2012-000935","volume":"19","author":"S Vilar","year":"2012","unstructured":"Vilar S, Harpaz R, Uriarte E, Santana L, Rabadan R, Friedman C. Drug-drug interaction through molecular structure similarity analysis. J Am Med Inform Assoc. 2012;19:1066\u201374.","journal-title":"J Am Med Inform Assoc"},{"key":"4241_CR25","doi-asserted-by":"crossref","unstructured":"Jin B, Yang H, Xiao C, Zhang P, Wei X, Wang F. Multitask dyadic predictiondyadic prediction and its application in prediction of adverse drug-drug interaction. Adverse drug-drug interaction. In: Proceedings of the AAAI conference on artificial intelligence. 2017, 31(1).","DOI":"10.1609\/aaai.v31i1.10718"},{"key":"4241_CR26","doi-asserted-by":"crossref","unstructured":"Ma T, Xiao C, Zhou J, Wang F. Drug similarity integration through attentive multidrug similarity integration through attentive multi-view Graph Auto-Encoders.graph auto-encoders. 2018. arXiv. preprint http:\/\/arxiv.org\/abs\/1804.10850.","DOI":"10.24963\/ijcai.2018\/483"},{"key":"4241_CR27","unstructured":"https:\/\/lincsproject.org"},{"key":"4241_CR28","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171:1437\u201352.","journal-title":"Cell"},{"key":"4241_CR29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12859-018-2544-0","volume":"19","author":"S Dey","year":"2018","unstructured":"Dey S, Luo H, Fokoue A, Hu J, Zhang P. Predicting adverse drug reactions through interpretable deep learning framework. BMC Bioinform. 2018;19:476.","journal-title":"BMC Bioinform"},{"key":"4241_CR30","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1021\/acs.molpharmaceut.6b00248","volume":"13","author":"A Aliper","year":"2016","unstructured":"Aliper A, Plis S, Artemov A, Ulloa A, Mamoshina P, Zhavoronkov A. Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data. Mol Pharm. 2016;13:2524\u201330.","journal-title":"Mol Pharm"},{"key":"4241_CR31","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1021\/acs.molpharmaceut.8b00284","volume":"15","author":"Y Donner","year":"2018","unstructured":"Donner Y, Kazmierczak S, Fortney K. Drug repurposing using deep embeddings of gene expression profiles. Mol Pharm. 2018;15:4314\u201325.","journal-title":"Mol Pharm"},{"key":"4241_CR32","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/s12864-018-5031-0","volume":"19","author":"L Xie","year":"2018","unstructured":"Xie L, He S, Song X, Bo X, Zhang Z. Deep learning-based transcriptome data classification for drug-target interaction prediction. BMC Genom. 2018;19:667.","journal-title":"BMC Genom"},{"key":"4241_CR33","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucl Acids Res. 2018;46:D1074\u201382.","journal-title":"Nucl Acids Res."},{"key":"4241_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12024-010-9188-3","volume":"7","author":"JL Pilgrim","year":"2011","unstructured":"Pilgrim JL, Gerostamoulos D, Drummer OH. Review: pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol. 2011;7:162\u201384.","journal-title":"Forensic Sci Med Pathol"},{"key":"4241_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/1389450118666170125144557","volume":"19","author":"P Manikandan","year":"2018","unstructured":"Manikandan P, Nagini S. Cytochrome P450 structure, function and clinical significance: a review. Curr Drug Targets. 2018;19:38\u201354.","journal-title":"Curr Drug Targets"},{"key":"4241_CR36","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s40264-014-0223-2","volume":"37","author":"M Amin","year":"2014","unstructured":"Amin M, Suksomboon N. Pharmacotherapy of type 2 diabetes mellitus: an update on drug-drug interactions. Drug Saf. 2014;37:903\u201319.","journal-title":"Drug Saf"},{"key":"4241_CR37","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X, et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucl Acids Res. 2017;45:W356\u201360.","journal-title":"Nucl Acids Res"},{"key":"4241_CR38","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/j.xphs.2017.04.078","volume":"106","author":"X Liang","year":"2017","unstructured":"Liang X, Giacomini KM. Transporters involved in metformin pharmacokinetics and treatment response. J Pharm Sci. 2017;106:2245\u201350.","journal-title":"J Pharm Sci"},{"key":"4241_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","volume":"50","author":"GG Graham","year":"2011","unstructured":"Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, et al. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 2011;50:81\u201398.","journal-title":"Clin Pharmacokinet"},{"key":"4241_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejps.2016.03.020","volume":"88","author":"HJ Burt","year":"2016","unstructured":"Burt HJ, Neuhoff S, Almond L, Gaohua L, Harwood MD, Jamei M, et al. Metformin and cimetidine: physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions. Eur J Pharm Sci. 2016;88:70\u201382.","journal-title":"Eur J Pharm Sci"},{"key":"4241_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2015.10.023","volume":"240","author":"B Phong","year":"2016","unstructured":"Phong B, Benjamin J, Rabenau M, et al. Delivery of drugs and macromolecules to the mitochondria for cancer therapy. J Control Release Off J Control Release Soc. 2016;240:38\u201351.","journal-title":"J Control Release Off J Control Release Soc"},{"key":"4241_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.addr.2016.01.010","volume":"101","author":"E Moroz","year":"2016","unstructured":"Moroz E, Matoori S, Leroux JC. Oral delivery of macromolecular drugs: where we are after almost 100years of attempts. Adv Drug Deliv Rev. 2016;101:108\u201321.","journal-title":"Adv Drug Deliv Rev"},{"key":"4241_CR43","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1109\/TNB.2015.2391175","volume":"14","author":"L Wu","year":"2015","unstructured":"Wu L, Shen Y, Li M, Wu FX. Network output controllability-based method for drug target identification. IEEE Trans Nanobiosci. 2015;14:184\u201391.","journal-title":"IEEE Trans Nanobiosci"},{"key":"4241_CR44","first-page":"1070","volume":"17","author":"F Barneh","year":"2016","unstructured":"Barneh F, Jafari M, Mirzaie M. Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database. Brief Bioinform. 2016;17:1070\u201380.","journal-title":"Brief Bioinform"},{"key":"4241_CR45","doi-asserted-by":"publisher","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","volume":"44","author":"M Kuhn","year":"2016","unstructured":"Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucl Acids Res. 2016;44:D1075\u20139.","journal-title":"Nucl Acids Res"},{"key":"4241_CR46","doi-asserted-by":"publisher","first-page":"D330","DOI":"10.1093\/nar\/gky1055","volume":"47","author":"The Gene Ontology Consortium","year":"2019","unstructured":"The Gene Ontology Consortium. The gene ontology resource: 20 years and still going strong. Nucl Acids Res. 2019;47:D330\u20138.","journal-title":"Nucl Acids Res"},{"key":"4241_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.aiopen.2021.01.001","volume":"1","author":"J Zhou","year":"2020","unstructured":"Zhou J, Cui G, Hu S, Zhang Z, Yang C, Liu Z, et al. Graph neural networks: a review of methods and applications. AI Open. 2020;1:57\u201381.","journal-title":"AI Open"},{"key":"4241_CR48","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1021\/jm401411z","volume":"57","author":"G Maggiora","year":"2014","unstructured":"Maggiora G, Vogt M, Stumpfe D, Bajorath J. Molecular similarity in medicinal chemistry. J Med Chem. 2014;57:3186\u2013204.","journal-title":"J Med Chem"},{"key":"4241_CR49","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-04241-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-021-04241-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-04241-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T19:25:22Z","timestamp":1672428322000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-021-04241-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4241"],"URL":"https:\/\/doi.org\/10.1186\/s12859-021-04241-1","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"20 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}